CervoMed presents neflamapimod DLB trial data at AAIC 2026
Go back to CervoMed presents neflamapimod DLB trial data at AAIC 2026| (NASDAQ: CRVO) | Delayed: 3.18 -0.16 (4.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.34 | 52 Week High | $ | |||
| Open | $3.26 | 52 Week Low | $ | |||
| Day High | $3.36 | P/E | N/A | |||
| Day Low | $3.13 | EPS | $ | |||
| Volume | 309,462 | |||||



